Badre Hammond
Director, Corporate Business Integration

About

Badre Hammond, MBA, is Director, Corporate Business Integration, at AptarGroup, with a background in biochemistry and 14 years’ experience in pharmaceutical product development focusing on nasal and pulmonary drug delivery systems. Mr Hammond has broad experience in managing development of novel drug product programmes for the pharmaceutical market from formulation development, preclinical, CMC, to clinical phase.

Contributions

NASAL

DRUG REPURPOSING – BROADENING PATIENT ACCESSIBILITY VIA A CHANGE IN DRUG DELIVERY SYSTEM

Badre Hammond, Gerallt Williams and Herve Pacaud discuss the growing trend of drug repurposing.

More contributions

PULMONARY

GENERIC PMDI PRODUCT DEVELOPMENT FOR THE US: KEY CONSIDERATIONS

Badre Hammond highlights key considerations and addresses strategies that are believed to reduce risk and ultimately speed up the process for getting a generic pMDI product to the US market.

OCULAR

REDUCE RISKS, MITIGATE FAILURE & DRIVE TIMELINES IN A COMPETITIVE MARKET

Badre Hammond, Shailuja Somaraju and Julie Suman highlight key considerations and present strategies to reduce risk and ultimately accelerate the process for gaining approval of an ophthalmic product, with a focus on the US.